Efficacy of Maternal Influenza Vaccination Against All-Cause Lower Respiratory Tract Infection Hospitalizations in Young Infants: Results from a Randomized Controlled Trial

Clinical Infectious Diseases

Volumn 65, Issue 7, 2017, Pages 1066-1071

  Nunes, Marta C ^a,b   Cutland, Clare L ^a,b   Jones, Stephanie ^a,b   Downs, Sarah ^a,b   Weinberg, Adriana ^c   Ortiz, Justin R ^d   Neuzil, Kathleen M ^e   Simões, Eric A F ^b,f   Klugman, Keith P ^g   Madhi, Shabir A ^a,b,h  

^a Vaccine Preventable Diseases   (Australia)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

^f University of Colorado Denver and Children s Hospital Colorado   (United States)

^g UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^h NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

Author keywords

efficacy; hospitalizations; influenza vaccine; lower respiratory tract infections; phase 3 trial

Indexed keywords

INFLUENZA VACCINE; PLACEBO; INACTIVATED VACCINE;

ARTICLE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITALIZATION; HOSPITALIZED INFANT; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFANT; INFLUENZA; INFLUENZA VACCINATION; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHASE 3 CLINICAL TRIAL; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOVIRUS; CLINICAL TRIAL; IMMUNOLOGY; NEWBORN; PREGNANCY COMPLICATION; PROCEDURES; RESPIRATORY TRACT INFECTION; VACCINATION;

DOUBLE-BLIND METHOD; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RESPIRATORY TRACT INFECTIONS; VACCINATION; VACCINES, INACTIVATED;

EID: 85029000370     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix497     Document Type: Article

References (35)

1. Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet 2016; 388:3027-35.
2. Nair H, Simões EA, Rudan I, et al; Severe Acute Lower Respiratory Infections Working Group. Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet 2013; 381:1380-90.
3. Weinberger DM, Simonsen L, Jordan R, Steiner C, Miller M, Viboud C. Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States. J Infect Dis 2012; 205:458-65.
4. Shrestha S, Foxman B, Berus J, et al. The role of influenza in the epidemiology of pneumonia. Sci Rep 2015; 5:15314.
5. Jain S, Williams DJ, Arnold SR, et al; CDC EPIC Study Team. Communityacquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 2015; 372:835-45.
6. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000; 342:225-31.
7. Grijalva CG, et al. The role of influenza and parainfluenza infections in nasopharyngeal pneumococcal acquisition among young children. Clin Infect Dis 2014; 58:1369-76.
8. Gray BM, Converse GM III, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980; 142:923-33.
9. Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008; 359:1555-64.
10. Madhi SA, Cutland CL, Kuwanda L, et al; Maternal Flu Trial (Matflu) Team. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 2014; 371:918-31.
11. Tapia MD, Sow SO, Tamboura B, et al. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial. Lancet Infect Dis 2016; 16:1026-35.
12. Nunes MC, Cutland CL, Jones S, et al; Maternal Flu Trial Team. Duration of infant protection against influenza illness conferred by maternal immunization: secondary analysis of a randomized clinical trial. JAMA Pediatr 2016; 170:840-7.
13. Benowitz I, Esposito DB, Gracey KD, Shapiro ED, Vázquez M. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis 2010; 51:1355-61.
14. Black SB, Shinefield HR, France EK, Fireman BH, Platt ST, Shay D; Vaccine Safety Datalink Workgroup. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol 2004; 21:333-9.
15. Dabrera G, Zhao H, Andrews N, et al. Effectiveness of seasonal influenza vaccination during pregnancy in preventing influenza infection in infants, England, 2013/14. Euro Surveill 2014; 19:20959.
16. Eick AA, Uyeki TM, Klimov A, et al. Maternal influenza vaccination and effect on influenza virus infection in young infants. Arch Pediatr Adolesc Med 2011; 165:104-11.
17. France EK, Smith-Ray R, McClure D, et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Arch Pediatr Adolesc Med 2006; 160:1277-83.
18. Poehling KA, Szilagyi PG, Staat MA, et al; New Vaccine Surveillance Network. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol 2011; 204:S141-8.
19. Regan AK, de Klerk N, Moore HC, Omer SB, Shellam G, Effler PV. Effect of maternal influenza vaccination on hospitalization for respiratory infections in newborns: a retrospective cohort study. Pediatr Infect Dis J 2016; 35:1097-103.
20. World Health Organization. Recommended viruses for influenza vaccines for use in the 2011 Southern Hemisphere influenza season. Geneva, Switzerland: WHO, 2010. Available at: http://www.who.int/ influenza/vaccines/ virus/recommendations/ 201009-Recommendation.pdf?ua=1. Accessed 7 June 2016.
21. VAXIGRIP. Inactivated influenza vaccine (split virion) product information. Lyon, France: Sanofi Pasteur, 2011. Available at: http://www.sanofipasteur.com/ en. Accessed 7 June 2016.
22. National Institute for Communicable Diseases, National Health Laboratory Service. Influenza surveillance report-South Africa. Available at: http://www. nicd.ac.za/?page=seasonal-influenza&id=72. Accessed 7 June 2016.
23. McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 2002; 186:341-50.
24. Nunes MC, Kuschner Z, Rabede Z, et al. Polyomaviruses-associated respiratory infections in HIV-infected and HIV-uninfected children. J Clin Virol 2014; 61:571-8.
25. Madhi SA, Klugman KP; Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004; 10:811-3.
26. Madhi SA, Ludewick H, Kuwanda L, et al. Pneumococcal coinfection with human metapneumovirus. J Infect Dis 2006; 193:1236-43.
27. Madhi SA, Kuwanda L, Cutland C, Klugman KP. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIVinfected and-uninfected children. Clin Infect Dis 2005; 40:1511-8.
28. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198:962-70.
29. Mina MJ, Klugman KP. The role of influenza in the severity and transmission of respiratory bacterial disease. Lancet Respir Med 2014; 2:750-63.
30. Sun K, Metzger DW. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med 2008; 14:558-64.
31. Lee LN, Dias P, Han D, et al. A mouse model of lethal synergism between influenza virus and Haemophilus influenzae. Am J Pathol 2010; 176:800-11.
32. Iverson AR, Boyd KL, McAuley JL, Plano LR, Hart ME, McCullers JA. Influenza virus primes mice for pneumonia from Staphylococcus aureus. J Infect Dis 2011; 203:880-8.
33. Wolter N, Tempia S, Cohen C, et al. High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia. J Infect Dis 2014; 210:1649-57.
34. Rudan I, O'Brien KL, Nair H, et al; Child Health Epidemiology Reference Group (CHERG). Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health 2013; 3:010401.
35. Feikin DR, Scott JA, Gessner BD. Use of vaccines as probes to define disease burden. Lancet 2014; 383:1762-70.